JAMP-CHOLESTYRAMINE DIN 02494531
Health Canada record
| Active ingredient(s) | CHOLESTYRAMINE RESIN 4 G |
|---|---|
| Dosage form | Powder For Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AC01 COLESTYRAMINE |
| Original market date | |
| Current status date | 29-Nov-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CHOLESTYRAMINE RESIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02455609 | CHOLESTYRAMINE-ODAN | ODAN LABORATORIESLTD | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Marketed |
| 02478595 | JAMP-CHOLESTYRAMINE | JAMP PHARMA CORPORATION | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Marketed |
| 02210320 | OLESTYR | PHARMASCIENCE INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Marketed |
| 02054825 | ALTI-CHOLESTYRAMINE LIGHT | ALTIMED PHARMA INC. | Powder; Package | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02236969 | CHOLESTYRAMINE | SORRES PHARMA INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02236970 | CHOLESTYRAMINE | SORRES PHARMA INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02139189 | NOVO-CHOLAMINE - PWR 4G/DOSE | NOVOPHARM LIMITED | Suspension; Powder | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02139197 | NOVO-CHOLAMINE LIGHT - PWR 4G/DOSE | NOVOPHARM LIMITED | Powder; Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 00890960 | OLESTYR | PHARMASCIENCE INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Dormant |
| 02237132 | PHL-CHOLESTYRAMINE LIGHT - 210G TIN | PHARMEL INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02259249 | PHL-CHOLESTYRAMINE POWDER 210G/CAN | PHARMEL INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02259257 | PHL-CHOLESTYRAMINE POWDER FOR SUSPENSION 400GM/CAN | PHARMEL INC | Powder For Suspension | CHOLESTYRAMINE RESIN 400 G | Cancelled Post Market |
| 02237133 | PHL-CHOLESTYRAMINE REGULAR - 378G TIN | PHARMEL INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02458365 | PMS-CHOLESTYRAMINE | PHARMASCIENCE INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Pre Market |
| 02458373 | PMS-CHOLESTYRAMINE | PHARMASCIENCE INC | Powder For Suspension | CHOLESTYRAMINE RESIN 4 G | Cancelled Pre Market |
| 02141795 | PMS-CHOLESTYRAMINE POWDER 210G/CAN | PHARMASCIENCE INC | Powder For Solution | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 02125463 | PMS-CHOLESTYRAMINE PWS 400G/CAN | PHARMASCIENCE INC | Powder For Solution | CHOLESTYRAMINE RESIN 400 G | Cancelled Post Market |
| 02207745 | PMS-CHOLESTYRAMINE REGULAR POWDER -4/9G DOSE | PHARMASCIENCE INC | Powder | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 01918486 | QUESTRAN LIGHT PWS 4GM/PCK | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 00634093 | QUESTRAN PWR 378GM/CAN | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 00464880 | QUESTRAN PWR 4GM/9GM | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | CHOLESTYRAMINE RESIN 4 G | Cancelled Post Market |
| 01966014 | QUESTRAN TAB 1GM | BRISTOL-MYERS SQUIBB CANADA | Tablet | CHOLESTYRAMINE RESIN 1 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22963 | 2019-11-29 | Supplement to an Abbreviated New Drug Submission (SANDS) | NEW FORMULATION. REVISIONS TO THE PRODUCT MONOGRAPH AND LABELLING |
International API supply for CHOLESTYRAMINE RESIN
5 active FDA Drug Master Files.
Request a quote for JAMP-CHOLESTYRAMINE